ImmunityBio (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced completion of enrollment in its Phase 2 clinical trial evaluating ANKTIVA® (nogapendekin alfa inbakicept-pmln) ...
News-Medical.Net on MSN
Study reveals coffee triggers distinct cytokine responses compared with pure caffeine
By Vijay Kumar Malesu A controlled human study reveals that coffee’s complex chemical matrix may shape immune responses ...
When Elise Felicione tried to design a clinical trial for a supplement, 5 things got in the way. It’s a lesson for the ...
Findings from the VA’s Diuretic Comparison Project show pragmatic trial designs can achieve strong provider participation when burden is minimized and patient care remains the primary focus.
News-Medical.Net on MSN
Colonoscopy and FIT at age 60 catch colorectal cancer earlier
By Dr. Priyom Bose, Ph.D. Inviting adults to colorectal cancer screening at age 60 shifts diagnoses to earlier stages without ...
Recently published single‑center cohort study explored whether a structured blood conservation protocol could safely reduce transfusion requirements and improve recovery in adults undergoing ...
The University of Warwick, which is setting up the Registry, plans to collect data for analysis from 500 AML patients at sites in 30 large metropolitan NHS hospitals across the UK by the end of this ...
Turn Therapeutics (NASDAQ:TTRX) executives outlined the company’s focus on inflammatory skin disease and provided updates on its lead topical candidate, GX-03, during a presentation at an ...
MedPage Today on MSN
Group Therapy, Developed With Help of Patients, Cut Postpartum Depression
Intervention informed by community was especially effective for those with baseline depres ...
Ooops... Something went wrong while loading this page.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results